{"id":142141,"date":"2025-01-07T11:22:15","date_gmt":"2025-01-07T05:52:15","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=142141"},"modified":"2025-01-07T11:22:17","modified_gmt":"2025-01-07T05:52:17","slug":"pharma-stock-jumps-4-after-receiving-approval-from-usfda-for-its-new-drug-to-treat-menkes-disease","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-receiving-approval-from-usfda-for-its-new-drug-to-treat-menkes-disease\/","title":{"rendered":"Pharma stock jumps 4% after receiving approval from USFDA for its new drug to treat Menkes disease"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-383530497\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>The Indian pharmaceutical industry is a global leader, ranking third in volume and 14th in value, with a market size of over $50 billion. Known as the \u201cpharmacy of the world,\u201d it supplies 20% of global generic medicines and is a key player in vaccines, exporting to over 200 countries. The industry is driven by strong R&amp;D, cost-effective manufacturing, and a skilled workforce.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2056248810\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>Companies like Sun Pharma, Dr. Reddy\u2019s, Zydus Lifesciences, Cipla, and Lupin lead the sector. With increasing healthcare spending, rising chronic diseases, and export demand, India\u2019s pharma industry has immense growth potential, especially in biotechnology, biosimilars, and innovative drug development.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>India: The CDMO Capital of the World&nbsp;<\/strong><\/h2><p>India is known as the &#8220;CDMO (Contract Development and Manufacturing Organization) capital of the world,&#8221; dominating the global pharmaceutical outsourcing market. Indian companies provide end-to-end solutions, including drug development, manufacturing, and packaging, to major global pharma players. The country\u2019s competitive pricing, skilled workforce, and regulatory expertise make it the preferred hub for outsourced pharmaceutical services.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Share Price&nbsp;<\/strong><\/h2><p>The shares of <strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/ZYDUSLIFE\" target=\"_blank\" rel=\"noreferrer noopener\">Zydus Lifescience Limited<\/a><\/strong> are currently trading at Rs. 997.4 up by 3.7% from its previous close of Rs. 961.45 as of January 07, 2025\u00a0<\/p><div class=\"trade-content_5\" id=\"trade-1774489806\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Recent Updates&nbsp;<\/strong><\/h2><h3 class=\"wp-block-heading has-medium-font-size\"><strong>FDA Acceptance and Priority Review for CUTX-101&nbsp;<\/strong><\/h3><p>Sentynl Therapeutics (Wholly Owned Subsidiary of Zydus Lifesciences Ltd.) has announced that the U.S. FDA has accepted its New Drug Application (NDA) for CUTX-101 (Copper Histidinate) to treat Menkes disease. The FDA has also granted a six-month priority review for the drug, with a target decision date of June 30, 2025.&nbsp;<\/p><h3 class=\"wp-block-heading has-medium-font-size\"><strong>Potential First Treatment for Menkes Disease&nbsp;<\/strong><\/h3><p>If approved, CUTX-101 could become the first-ever FDA-approved treatment for Menkes disease, a rare and serious condition that affects infants. Menkes disease leads to problems with copper in the body, causing severe developmental and neurological issues. This approval offers hope for children suffering from the disease.&nbsp;<\/p><h3 class=\"wp-block-heading has-medium-font-size\"><strong>Zydus Enters Agreement with CVS Caremark&nbsp;<\/strong><\/h3><p>Zydus Lifesciences Ltd., a global healthcare company, has announced a strategic agreement with CVS Caremark, a CVS Health company. Under this agreement, Zydus will add its drugs Zituvio, Zituvimet, and Zituvimet XR (Sitagliptin | Sitagliptin and Metformin Hydrochloride) tablets to the CVS Caremark template formulary, starting January 1, 2025. This partnership expands Zydus&#8217; reach in the U.S. market and enhances its portfolio of medications available to patients.<\/p><h3 class=\"wp-block-heading has-medium-font-size\"><strong>Medications Added to the CVS Caremark Formular&nbsp;<\/strong><\/h3><p>Zituvio is a medication used for the treatment of type 2 diabetes, while Zituvimet and Zituvimet XR combine sitagliptin and metformin hydrochloride, which are also prescribed for managing type 2 diabetes. These medicines work together to help control blood sugar levels in adults with this condition. Adding these products to CVS Caremark&#8217;s formulary makes them more accessible to a larger patient base.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>About the Company&nbsp;<\/strong><\/h2><p>Zydus Lifesciences Ltd. is a global healthcare company that focuses on innovation, research, and the development of high-quality medicines. With a strong presence in over 50 countries, the company offers a broad portfolio that includes branded and generic pharmaceuticals, biosimilars, and consumer healthcare products.&nbsp;<\/p><p>Zydus Lifesciences is dedicated to improving lives through cutting-edge healthcare solutions, and it invests heavily in research and development to drive innovation across various therapeutic areas. The company is committed to sustainability, quality, and making a positive impact on global health through its diverse range of medicines and wellness products.&nbsp;<\/p><div class=\"trade-content-10\" id=\"trade-3140558401\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written By: Dipangshu Kundu<\/strong><\/p><\/blockquote><p class=\"has-medium-font-size\"><strong>Disclaimer<\/strong><\/p><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on <a href=\"http:\/\/tradebrains.in\/\">tradebrains.in<\/a> are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-after-content\" id=\"trade-1096535135\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>The Indian pharmaceutical industry is a global leader, ranking third in volume and 14th in value, with a market size of over $50 billion. Known as the \u201cpharmacy of the world,\u201d it supplies 20% of global generic medicines and is a key player in vaccines, exporting to over 200 countries. The industry is driven by [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":125304,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[948,936,3157,26128,20598,14843,16292,14842],"class_list":["post-142141","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-stock-market","tag-stock-market-news","tag-stock-to-watch","tag-zydus-lifescience","tag-zydus-lifesciences","tag-zydus-lifesciences-latest-news","tag-zydus-lifesciences-new-medicine","tag-zydus-lifesciences-share-price"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock jumps 4% after receiving approval from USFDA for its new drug to treat Menkes disease - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"The Indian pharmaceutical industry is a global leader, ranking third in volume and 14th in value, with a market size of over $50 billion. Known as the \u201cpharmacy of the world,\u201d it supplies 20% of global generic medicines and is a key player in vaccines, exporting to over 200 countries.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-receiving-approval-from-usfda-for-its-new-drug-to-treat-menkes-disease\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock jumps 4% after receiving approval from USFDA for its new drug to treat Menkes disease\" \/>\n<meta property=\"og:description\" content=\"The Indian pharmaceutical industry is a global leader, ranking third in volume and 14th in value, with a market size of over $50 billion. Known as the \u201cpharmacy of the world,\u201d it supplies 20% of global generic medicines and is a key player in vaccines, exporting to over 200 countries.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-receiving-approval-from-usfda-for-its-new-drug-to-treat-menkes-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-07T05:52:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-07T05:52:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/USFDA.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-receiving-approval-from-usfda-for-its-new-drug-to-treat-menkes-disease\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-receiving-approval-from-usfda-for-its-new-drug-to-treat-menkes-disease\/\",\"name\":\"Pharma stock jumps 4% after receiving approval from USFDA for its new drug to treat Menkes disease - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-receiving-approval-from-usfda-for-its-new-drug-to-treat-menkes-disease\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-receiving-approval-from-usfda-for-its-new-drug-to-treat-menkes-disease\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/USFDA.jpg\",\"datePublished\":\"2025-01-07T05:52:15+00:00\",\"dateModified\":\"2025-01-07T05:52:17+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"The Indian pharmaceutical industry is a global leader, ranking third in volume and 14th in value, with a market size of over $50 billion. Known as the \u201cpharmacy of the world,\u201d it supplies 20% of global generic medicines and is a key player in vaccines, exporting to over 200 countries.\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-receiving-approval-from-usfda-for-its-new-drug-to-treat-menkes-disease\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-receiving-approval-from-usfda-for-its-new-drug-to-treat-menkes-disease\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-receiving-approval-from-usfda-for-its-new-drug-to-treat-menkes-disease\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/USFDA.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/USFDA.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-receiving-approval-from-usfda-for-its-new-drug-to-treat-menkes-disease\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock jumps 4% after receiving approval from USFDA for its new drug to treat Menkes disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock jumps 4% after receiving approval from USFDA for its new drug to treat Menkes disease - Trade Brains Features","description":"The Indian pharmaceutical industry is a global leader, ranking third in volume and 14th in value, with a market size of over $50 billion. Known as the \u201cpharmacy of the world,\u201d it supplies 20% of global generic medicines and is a key player in vaccines, exporting to over 200 countries.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-receiving-approval-from-usfda-for-its-new-drug-to-treat-menkes-disease\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock jumps 4% after receiving approval from USFDA for its new drug to treat Menkes disease","og_description":"The Indian pharmaceutical industry is a global leader, ranking third in volume and 14th in value, with a market size of over $50 billion. Known as the \u201cpharmacy of the world,\u201d it supplies 20% of global generic medicines and is a key player in vaccines, exporting to over 200 countries.","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-receiving-approval-from-usfda-for-its-new-drug-to-treat-menkes-disease\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2025-01-07T05:52:15+00:00","article_modified_time":"2025-01-07T05:52:17+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/USFDA.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-receiving-approval-from-usfda-for-its-new-drug-to-treat-menkes-disease\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-receiving-approval-from-usfda-for-its-new-drug-to-treat-menkes-disease\/","name":"Pharma stock jumps 4% after receiving approval from USFDA for its new drug to treat Menkes disease - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-receiving-approval-from-usfda-for-its-new-drug-to-treat-menkes-disease\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-receiving-approval-from-usfda-for-its-new-drug-to-treat-menkes-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/USFDA.jpg","datePublished":"2025-01-07T05:52:15+00:00","dateModified":"2025-01-07T05:52:17+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"The Indian pharmaceutical industry is a global leader, ranking third in volume and 14th in value, with a market size of over $50 billion. Known as the \u201cpharmacy of the world,\u201d it supplies 20% of global generic medicines and is a key player in vaccines, exporting to over 200 countries.","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-receiving-approval-from-usfda-for-its-new-drug-to-treat-menkes-disease\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-receiving-approval-from-usfda-for-its-new-drug-to-treat-menkes-disease\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-receiving-approval-from-usfda-for-its-new-drug-to-treat-menkes-disease\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/USFDA.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/USFDA.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-receiving-approval-from-usfda-for-its-new-drug-to-treat-menkes-disease\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock jumps 4% after receiving approval from USFDA for its new drug to treat Menkes disease"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/142141","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=142141"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/142141\/revisions"}],"predecessor-version":[{"id":142142,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/142141\/revisions\/142142"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/125304"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=142141"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=142141"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=142141"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}